Mdivi-1 induces spindle abnormalities and augments taxol cytotoxicity in MDA-MB-231 cells

Taxol is a first-line chemotherapeutic for numerous cancers, including the highly refractory triple-negative breast cancer (TNBC). However, it is often associated with toxic side effects and chemoresistance in breast cancer patients, which greatly limits the clinical utility of the drug. Hence, comp...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Chieh-Ting, Kuo, Hsiao-Hui, Yuan, Chia-Jung, Yao, Jhong-Syuan, Yih, Ling-Huei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8137698/
https://www.ncbi.nlm.nih.gov/pubmed/34016960
http://dx.doi.org/10.1038/s41420-021-00495-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8137698/
https://www.ncbi.nlm.nih.gov/pubmed/34016960
http://dx.doi.org/10.1038/s41420-021-00495-z

Ejemplares similares